K E Opheim - Concepedia

Author

K E Opheim

University of Washington

Also Known As

K E Opheim, K Opheim, K. E. OPHEIM, K. E. Opheim, K. OPHEIM, K. Opheim, K.E. Opheim, K. E. Opheim, Kara Opheim

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Washington Addiction Research Foundation Cornell University Seattle Children's Hospital Seattle University

About

K E Opheim is an author at University of Washington specializing in pharmacology, medicine, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	330
2	Natural Sciences	4	4	88
3	Engineering	1	1	34
4	Health Sciences	1	1	19
5	Allergy	1	1	12

K E Opheim

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Purification and properties Brian M. Cox, K E Opheim, H. Teschemacher, Life Sciences BiochemistryWater PurificationPurification MethodChromatographyProtein Purification	1975	1.7K
Isolation H. Teschemacher, K E Opheim, Brian M. Cox, Life Sciences	1975	285
Pharmacokinetic Disposition of Zidovudine during Pregnancy D. Heather Watts, Zane A. Brown, Tommaso Tartaglione, The Journal of Infectious Diseases	1991	114
Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model Maria Corinna Palanca-Wessels, Aloysius J. Klingelhutz, Brian J. Reid, Carcinogenesis	2003	73
Determination of free digoxin concentrations in serum for monitoring Fab treatment of digoxin overdose. Marcie J. Hursting, Vidmantas A. Raisys, K E Opheim, Clinical Chemistry Ultrafiltration TechniqueDialysis TherapyPharmacokineticsRenal FunctionDigoxin Overdose	1987	63
Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography Allan Weber, Donald O. Chaffin, Arnold L. Smith, Antimicrobial Agents and Chemotherapy New QuinolineUv AbsorptionDrug ResistanceBioanalysisAnalytical Chemistry	1985	57
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062) Kate H. Moore, Ralph H. Raasch, Kim L. R. Brouwer, Antimicrobial Agents and Chemotherapy Hepatic DiseasePharmacologyAntiviral Drug DevelopmentAntiviral TherapyPharmacokinetic Parameters	1995	43
Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 region of the rat hippocampus. Terry L. Wimpey, K E Opheim, Charles Chavkin Journal of Pharmacology and Experimental Therapeutics	1989	41
Gyrinidal: A Sesquiterpenoid Aldehyde from the Defensive Glands of Gyrinid Beetles Jerrold Meinwald, K E Opheim, Thomas Eisner Proceedings of the National Academy of Sciences EngineeringD. SerrulatusEntomologyFunctionalized TerpeneSecondary Metabolite	1972	34
Multiple fetal anomalies associated with subtle subtelomeric chromosomal rearrangements Vivienne Souter, Ian A. Glass, Daniel Chapman, Ultrasound in Obstetrics and Gynecology	2003	29

Page 1